Singulair Advantage In Allergies Is Leukotriene-Blocking Action, Merck Says

Merck's Singulair AR novel mechanism of action allows the asthma drug to work across multiple allergic rhinitis symptoms, Human Health President-Americas David Anstice told investors

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet